{"id":"https://openalex.org/A5093767199","orcid":"https://orcid.org/0009-0008-8043-236X","observed_orcids":["https://orcid.org/0009-0008-8043-236X"],"display_name":"Ryoko Kikuyama","raw_author_names":["Ryoko Kikuyama"],"full_name":"Ryoko Kikuyama","works_count":3,"cited_by_count":5,"summary_stats":{"2yr_mean_citedness":1.6666666666666667,"h_index":2,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5093767199","orcid":"https://orcid.org/0009-0008-8043-236X","observed_orcids":["https://orcid.org/0009-0008-8043-236X"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210090259","ror":"https://ror.org/0097kbr85","display_name":"ASKA Pharmaceutical (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210090259"]},"years":[2026,2025,2024]}],"last_known_institutions":[{"id":"https://openalex.org/I4210090259","ror":"https://ror.org/0097kbr85","display_name":"ASKA Pharmaceutical (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210090259"]}],"topics":[{"id":"https://openalex.org/T10600","display_name":"Reproductive Health and Contraception","count":3,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":2,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11964","display_name":"Pregnancy and Medication Impact","count":2,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":1,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","count":1,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11964","display_name":"Pregnancy and Medication Impact","value":1.42e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":7.9e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10600","display_name":"Reproductive Health and Contraception","value":6.7e-06,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","value":5.3e-06,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","value":2.3e-06,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"2780330700","wikidata":"https://www.wikidata.org/wiki/Q419646","display_name":"Drospirenone","score":0.9869918823242188},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9689000248908997},{"id":"81603835","wikidata":"https://www.wikidata.org/wiki/Q3457430","display_name":"Pill","score":0.7013000249862671},{"id":"197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","score":0.6983000040054321},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.3448818027973175}],"counts_by_year":[{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2025,"works_count":1,"oa_works_count":1,"cited_by_count":1},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":4}],"display_name_alternatives":["Ryoko Kikuyama"],"block_key":"r kikuyama","works_api_url":"https://api.openalex.org/works?filter=author.id:A5093767199","awards_count":0,"updated_date":"2026-10-27T12:30:23","created_date":"2024-01-24T00:00:00"}